Paraoxonase gene polymorphism and the risk for alzheimer's disease in the polish population

Dementia and Geriatric Cognitive Disorders

Volumn 31, Issue 6, 2011, Pages 417-423

  Klimkowicz Mrowiec, A ^a   Marona, M ^c   Wolkow, P ^b   Witkowski, A ^b   Maruszak, A ^d   Styczynska, M ^d   Barcikowska, M ^d   Szczudlik, A ^a   Slowik, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alzheimer's disease, meta analyses; Genetic risk factors; Paraoxonase; Polish population

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 79960223298     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000329571     Document Type: Article

References (30)

1. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN: The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics 1996; 33: 498-507.
2. Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473-480.
3. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM: Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001; 21: 542-547.
4. Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, Tsui LC, Prochazka M: Human PON2 gene at 7q21.3: Cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 1998; 213: 149-157.
5. Byrk B, Ben Moyal-Segal L, Podoly E, Livnah O, Eisenkraft A, Luria S, Cohen A, Yehezkelli Y, Hourvitz A, Soreq H: Inherited and acquired interactions between AchE and PON1 polymorphisms modulate plasma acetylocholinesterase and paraoxonase activities. J Neurochem 2005; 92: 1216-1227.
6. Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN: Rabbit serum paraoxonase 3 (PON3) is a high density lipoproteinassociated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 2000; 275: 33435-33442.
7. Harel M, Brumshtein B, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL: 3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability. Arh Hig Rada Toksikol 2007; 58: 347-353.
8. Boright AP, Connelly PW, Brunt JH, Scherer SW, Tsui LC, Hegele RA: Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites. Atherosclerosis 1998; 139: 131-136.
9. Sodeyama N, Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E, Mizusawa H: No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease. Neurology 1999; 53: 1146-1148.
10. Zuliani G, Ble A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R: Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 2001; 103: 304-308.
11. Dantoine TF, Drouet M, Debord J, Merle L, Cogne M, Charmes JP: Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Ann NY Acad Sci 2002; 977: 239-244.
12. Janka Z, Juhász A, Rimanóczy AA, Boda K, Márki-Zay J, Kálmán J: Codon 311 (Cys ] Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol Psychiatry 2002; 7: 110-112.
13. Pola R, Gaetani E, Flex A, Gerardino L, Aloi F, Flore R, Serricchio M, Pola P, Bernabei R: Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population. Dement Geriatr Cogn Disord 2003; 15: 88-91.
14. Scacchi R, Gambina G, Martini MC, Broggio E, Vilardo T, Corbo RM: Different pattern of association of paraoxonase Gln192 ] Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease. Neurosci Lett 2003; 339: 17-20.
15. Shi JJ, Zhang SZ, Ma C, Tang MN, Liu XH, Wang YC, Han HY, Guo YB, Feng RM, Miao GD: Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 371-314.
16. Cellini E, Tedde A, Bagnoli S, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S: Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Neurosci Lett 2006; 408: 199-202.
17. Erlich PM, Lunetta KL, Cupples LA, Huyck M, Green RC, Baldwin CT, Farrer LA, MIRAGE Study Group: Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet 2006; 15: 77-85.
18. He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB, Hong Z: Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population. Chin Med J (Engl) 2006; 119: 1204-1209.
19. Chapuis J, Boscher M, Bensemain F, Cottel D, Amouyel P, Lambert JC: Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease. Neurobiol Aging 2009; 30: 152-156.
20. McKhann G., Drachman D., Folstein M: Clinical diagnosis of Alzheimeŕs disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 1984; 34: 939-944.
21. Klimkowicz-Mrowiec A, Slowik A, Krzywoszanski L, Herzog-Krzywoszanska R, Szczudlik A: Severity of explicit memory impairment due to Alzheimer's disease improves effectiveness of implicit learning. J Neurol 2008; 20: 234-240.
22. Folstein MF, Folstein SE, McHugh PR: 'Mini mental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
23. Ombres D , Pannitteri G , Montali A, et al: The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients Arterioscler Thromb Vasc Biol 1998; 18: 1611 -1616.
24. Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI: Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) 2000; 98: 355-363.
25. Zawislak D, Ostrowska M, Golenia A, Marona M, Tomik B, Wolkow P, Gryz-Kurek E, Szczudlik A, Slowik A: The -A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis. Neurol Neurochir Pol 2010; 44: 246-50.
26. Dantoine TF, Debord J, Merle L, Lacroix-Ramiandrisoa H, Bourzeix L, Charmes JP: Paraoxonase 1 activity: A new vascular marker of dementia? Ann NY Acad Sci 2002; 977: 96-101.
27. Paragh G, Balla P, Katona E, Seres I, Egerházi A, Degrell I: Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 2002; 252: 63-67.
28. Wehr H, Bednarska-Makaruk M, Graban A, Lipczynska-Lojkowska W, Rodo M, Bochynska A, Ryglewicz D: Paraoxonase activity and dementia. J Neurol Sci 2009; 283: 107-108.
29. Leduc V, Poirier J: Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: Emphasis on the cholinergic system and beta-amyloid levels. Neurodegener Dis 2008; 5: 225-227.
30. Leduc V, Théroux L, Dea D, Robitaille Y, Poirier J: Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology. Eur J Neurosci 2009; 30: 1823-1830.